Health officials in Canada have updated their guidelines regarding respiratory syncytial virus (RSV) vaccines. The National Advisory Committee on Immunization (NACI) now recommends RSV vaccines for individuals aged 75 and older, especially those at higher risk of severe RSV. Additionally, vaccines are strongly recommended for those aged 60 and older residing in nursing homes or chronic care facilities (National Advisory Committee on Immunization, 2024).
RSV is a common contagious virus that can cause bronchiolitis and pneumonia. While infants are at the highest risk for severe RSV, older adults and those with certain medical conditions also face significant risks, including hospitalization and death (Public Health Agency of Canada, 2024).
RSV typically presents with mild, cold-like symptoms such as a runny nose, coughing, sneezing, wheezing, fever, and decreased appetite and energy. Symptoms usually appear two to eight days after exposure and can last one to two weeks. Treatment involves rest, hydration, and over-the-counter medications like acetaminophen or ibuprofen for fever. Severe cases require immediate medical attention (Public Health Agency of Canada, 2024).
